← All trials
NCT05859802
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2011
- Primary completion
- Mar 3, 2015
- Completion date
- Jan 9, 2016
- First posted
- May 16, 2023
- Last posted
- May 16, 2023
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- D'Youville CollegeLead sponsor
- Acorda TherapeuticsCollaborator
- University at BuffaloCollaborator
- D'Youville CollegeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.